Connect Biopharma Holdings (CNTB)
NASDAQ:CNTB
US Market
Holding CNTB?
Track your performance easily

Connect Biopharma Holdings (CNTB) Stock Investors

68 Followers
Based on 766,063 investor portfolios analyzed by TipRanks Open your own Smart Portfolio >

Average Holdings Size

<0.1% of all portfolios hold CNTB
On average, investors allocate 0.00% of their portfolios to CNTB
The average holding size of this company in investors' portfolios.

Investor Sentiment

Positive
Sector
Average
Stock Sentiment
Sold
Bought
Based on the activity of 766,063 investors in the recent quarter
The overall sentiment of all investors covering this stock. Click on ‘Top Investors’ to focus on the best performers.

Portfolios Holding CNTB

1.7%
Last 7
Days
3.2%
Last 30
Days
Percentages indicate the change in the number of portfolios holding CNTB, out of 766,063 portfolios.
The average increase or decrease in average holding size of this stock in investor portfolios in the last 7 days or last 30 days.

CNTB Investor Activity

Action
Any
Any
Investor Performance
Any
Any
No data currently available
Based on the activity of 14,653 investors who made their portfolios public
The table shows changes in CNTB in the past 3 months by investors with public portfolios.
Investor activity updates every 24 hours.

CNTB Investors Also Bought

Investor Type
Any
Any
All Investors
Name
Average Holding Size
Last 7D Change
Last 30D Change
Market Cap
Sector
3M Behavior
Follow
Viking Therapeutics
4.93%
+0.69%
+5.26%
7.63B
Healthcare
DraftKings
5.44%
+1.26%
-0.14%
35.26B
Consumer Cyclical
XPeng, Inc. ADR
5.57%
-0.86%
-1.05%
13.95B
Consumer Cyclical
Plug Power
5.22%
>-0.01%
+0.14%
1.81B
Industrials
Marathon Digital Holdings
5.76%
+0.26%
+0.42%
5.67B
Financial
Riot Platforms
5.31%
+0.17%
+1.75%
4.26B
Financial
Delta Air Lines
5.58%
-0.23%
-1.55%
39.39B
Industrials
Lucid Group
5.82%
+0.87%
+1.50%
6.66B
Consumer Cyclical
Bristol-Myers Squibb
3.48%
-0.30%
-2.11%
109.81B
Healthcare
PDD Holdings
5.05%
-1.89%
-2.71%
163.61B
Consumer Cyclical
Based on the activity of 766,063 active portfolios
Open your Smart Portfolio

CNTB Investor Analysis

CNTB investors under 35

Under 35

0.0%
Last 30 days
Holdings Change
10.7%
of CNTB holders
are under 35
Average Segment Performance
Average P/E Ratio26.57
Beta9.43
Dividend Yield51.54%
CNTB investors between 35–55

Between 35–55

0.0%
Last 30 days
Holdings Change
42.9%
of CNTB holders
are between 35–55
Average Segment Performance
Average P/E Ratio24.84
Beta18.28
Dividend Yield25.17%
CNTB investors over 55

Over 55

0.0%
Last 30 days
Holdings Change
46.4%
of CNTB holders
are over 55
Average Segment Performance
Average P/E Ratio23.97
Beta8.44
Dividend Yield41.02%
Overview of age group and performance of CNTB stock investors
See who invests in CNTB according to age group and performance.

FAQ

How many retail Investors hold CNTB?
<0.1% of TipRanks' retail investors hold CNTB in their portfolios.
    What is CNTB Investor Sentiment?
    CNTB’s Investor Sentiment is Positive.
      What percentage of retail investors changed their holding of CNTB in the last 7 days?
      ▼ 1.7% of TipRanks' retail investors changed their holding of CNTB in the last 7 days.
        What percentage of retail investors changed their holding of CNTB in the last 30 days?
        ▲ 3.2% of TipRanks' retail investors changed their holding of CNTB in the last 30 days.
          What is the average age of retail investors who hold CNTB?
          The average age of CNTB Holders is over 55.
            What other stocks have CNTB investors also bought?
            CNTB Investors also bought VKTX, DKNG, XPEV, PLUG, MARA, RIOT, DAL, LCID, BMY, PDD.
              Stocks with the Most Positive Individual Investor Sentiment in the Healthcare sector
              ABTAbbott Laboratories
              AAgilent
              BDXBecton Dickinson
              BMRNBioMarin Pharmaceutical
              CPRXCatalyst Pharma
              What am I Missing?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis